Compare ARK Genomic Revolution ETF (ARKG) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Cytokinetics Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Cytokinetics Inc trades at $76.67 (market cap $10.63B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CYTK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $87.26 |
52-Week Low | $24.02 | $34.31 |
Market Cap | — | $10.63B |
Enterprise Value | — | $10.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
